Syntal Capital Partners, LLC Laboratory Corp Of America Holdings Transaction History

Syntal Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$271.6 - $314.21 $1.5 Million - $1.74 Million	-5,540 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $138,509 - $155,403	-504 Reduced 8.34%	5,540 $1.56 Million
Q2 2021 Aug 12, 2021	SELL	$251.87 - $278.14 $852,579 - $941,503	-3,385 Reduced 35.9%	6,044 $1.67 Million
Q1 2021 May 17, 2021	BUY	$204.88 - $255.03 $1.93 Million - $2.4 Million	9,429 New	9,429 $2.4 Million
Q4 2019 Feb 10, 2020	SELL	$163.48 - $173.61 $1.04 Million - $1.11 Million	-6,378 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $919,452 - $1.1 Million	6,378 New	6,378 $1.1 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Syntal Capital Partners, LLC with notifications on news.